← headlines

The Trump administration is investing over $25 million to fast-track research on the psychedelic drug ibogaine to treat PTSD and other mental illnesses

Lifestyle – 13 outlets

The Independent

Trump team funds controversial psychedelic ibogaine for veteran PTSD study

Trump administration will fund new research on controversial psychedelic drug ibogaine

Boston Herald

Trump administration will fund new research on controversial psychedelic drug ibogaine

Local 10 WPLG

Trump administration will fund new research on controversial psychedelic drug ibogaine

Orlando Sentinel

Trump administration will fund new research on controversial psychedelic drug ibogaine

South Florida Sun Sentinel

Trump administration will fund new research on controversial psychedelic drug ibogaine

The Mercury News

Trump administration will fund new research on controversial psychedelic drug ibogaine

The Philadelphia Inquirer

Trump administration will fund new research on controversial psychedelic drug ibogaine

The San Diego Union-Tribune

Trump administration will fund new research on controversial psychedelic drug ibogaine

Toronto Star

Trump administration will fund new research on controversial psychedelic drug ibogaine seen

Washington Examiner

Trump administration fast-tracks ibogaine research for PTSD

Winnipeg Free Press

Trump administration will fund new research on controversial psychedelic drug ibogaine

WRAL

Trump administration will fund new research on controversial psychedelic drug ibogaine seen

Times Colonist

Trump administration will fund new research on controversial psychedelic drug ibogaine